09.01.2015 • News • BP • BP Chembel • Jacobs Engineering

Jacobs Engineering Wins BP Contract for Geel Upgrade

Jacobs Engineering Group has received a contract from BP Chembel for basic and detailed engineering services to upgrade that company's production facilities at Geel, Belgium.

BP Chembel is a major supplier of purified terephthalic acid (PTA) and paraxylene (PX) used to produce polyesters.

The California, USA-based engineering firm will install new equipment and performing upgrades in the facility's PTA units and optimize the site's operational performance.

In announcing the project, Jacobs Group vice president, Mark Bello, said the US contractor has "provided services" to BP at Geel for a number of years and is "delighted to further develop the relationship."

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

Top-Feature

most read

Photo
24.01.2025 • News

And the Winners are: Cynio, EnaDyne and Green Li-ion

The CHEManager Innovation Pitch, the start-up promotion initiative of CHEManager and CHEManager International, has given more than 100 start-ups from over 15 countries the opportunity to present their innovative ideas, products and technologies to a broad target group since its launch in 2019.

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.